Cunliffe Sean 4
4 · ANGIOTECH PHARMACEUTICALS INC · Filed May 16, 2011
Insider Transaction Report
Form 4
Cunliffe Sean
SVP, Sales & Marketing
Transactions
- Other
Common Stock
2009-09-08−70,700→ 70,700 total - Other
Stock Option w/Tandem SAR
2009-11-11−100,000→ 0 totalExercise: $1.28From: 2009-12-01Exp: 2014-11-10→ Common Stock (100,000 underlying) - Other
Stock Option w/Tandem SAR
2010-03-08−85,000→ 100,000 totalExercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
- [F2]Purchase price was not provided on Form 3 filing.